Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ANPEP | P15144 | 1/20 | 0.55 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.55 |
| ▸ | DNPEP | Q9ULA0 | 1/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | MME | P08473 | 1/20 | 0.51 |
| ▸ | ACE | P12821 | 1/20 | 0.49 |
| ▸ | CPA1 | P15085 | 2/20 | 0.49 |
| ▸ | CPA3 | P15088 | 2/20 | 0.49 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.49 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.49 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.49 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.49 |
| ▸ | CPB1 | P15086 | 1/20 | 0.49 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.49 |
| ▸ | MMP1 | P03956 | 2/20 | 0.48 |
| ▸ | MMP2 | P08253 | 1/20 | 0.48 |
| ▸ | MMP7 | P09237 | 1/20 | 0.48 |
| ▸ | MMP9 | P14780 | 1/20 | 0.48 |
| ▸ | MMP12 | P39900 | 1/20 | 0.48 |
| ▸ | MMP13 | P45452 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3928753 | 0.85 | CYP1A2 (0.70) | ANPEPRNPEPDNPEPCYP1A2MME | |
| SCHEMBL28126947 | 0.84 | CYP1A2 (0.57) | ANPEPRNPEPDNPEPCYP1A2MME | |
| SCHEMBL18623970 | 0.82 | CYP1A2 (0.55) | ANPEPRNPEPDNPEPCYP1A2MME | |
| SCHEMBL28411865 | 0.81 | CYP1A2 (0.53) | CYP1A2MMECPA1CPA3FOLH1 | |
| SCHEMBL12494053 | 0.81 | CYP1A2 (0.63) | ANPEPRNPEPDNPEPCYP1A2MME | |
| SCHEMBL19483376 | 0.81 | CYP1A2 (0.53) | CYP1A2MMECPA1CPA3SLC1A3 | |
| SCHEMBL23658187 | 0.79 | CYP1A2 (0.52) | CYP1A2MMECPA1CPA3FOLH1 | |
| SCHEMBL17087653 | 0.79 | CYP1A2 (0.52) | ANPEPRNPEPDNPEPCYP1A2MME | |
| SCHEMBL14874554 | 0.78 | HSD17B10 (0.56) | ANPEPRNPEPDNPEPCYP1A2MME | |
| SCHEMBL8345051 | 0.78 | HSD17B10 (0.56) | ANPEPRNPEPDNPEPCYP1A2MME |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11896704-B2 | Compounds useful for the treatment and/or care of the skin, hair, nails and/or mucous membranes | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2024-02-13 | — | — | US | disclosed |
| US-10035820-B2 | Compounds which inhibit neuronal exocytosis | LUBRIZOL ADVANCED MATERIALS, INC (US) | 2018-07-31 | — | — | US | disclosed |
| US-20170298097-A1 | Peptide Derivatives and Uses Thereof | NOSOPHARM (FR) | 2017-10-19 | — | — | US | disclosed |
| US-9771392-B2 | Compounds which inhibit neuronal exocytosis | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2017-09-26 | — | — | US | disclosed |
| US-20170218015-A1 | PROCESS FOR THE LIQUID PHASE SYNTHESIS OF H-INP-(D)BAL-(D)TRP-PHE-APC-NH2, AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | ALLERGAN GI CORP. | 2017-08-03 | — | — | US | disclosed |
| US-20170101438-A1 | COSMETIC OR PHARMACEUTICAL METHODS FOR THE TREATMENT AND/OR CARE OF THE SKIN AND/OR HAIR USING TRIPEPTIDES CAPABLE OF STIMULATING CYCLIC ADENOSINE MONOPHOSPHATE SYNTHESIS | LIPOTEC, S.A. | 2017-04-13 | — | — | US | disclosed |
| US-20150183823-A1 | COSMETIC OR PHARMACEUTICAL COMPOSITIONS INCLUDING TRIPEPTIDES CAPABLE OF STIMULATING CYCLIC ADENOSINE MONOPHOSPHATE SYNTHESIS AND THEIR USE IN THE TREATMENT AND/OR CARE OF THE SKIN AND/OR HAIR | LIPOTEC, S.A. | 2015-07-02 | — | — | US | disclosed |
| US-20150140046-A1 | COMPOUNDS WHICH INHIBIT NEURONAL EXOCYTOSIS | LUBRIZOL ADVANCED MATERIALS, INC. | 2015-05-21 | — | — | US | disclosed |
| US-20150098989-A1 | COMPOUNDS WHICH INHIBIT NEURONAL EXOCYTOSIS | LUBRIZOL ADVANCED MATERIALS, INC. | 2015-04-09 | — | — | US | disclosed |
| US-8653278-B2 | Isoform selective HDAC inhibitors | GEORGETOWN UNIVERSITY (US) | 2014-02-18 | — | — | US | disclosed |
| US-20120021029-A1 | PEPTIDES USED IN THE TREATMENT AND/OR CARE OF THE SKIN AND/OR HAIR AND THEIR USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS | LIPOTEC, S.A. (ES) | 2012-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150098989-A1 | COMPOUNDS WHICH INHIBIT NEURONAL EXOCYTOSIS | SLC18A2, SLC18A1, ATP6V1B2 | ANPEP 1013/4885RNPEP 1233/4885DNPEP 1574/4885 |
| US-11896704-B2 | Compounds useful for the treatment and/or care of the skin, hair, nails and/or mucous membranes | TYR, MTX1, MTX2 | ANPEP 188/4885RNPEP 911/4885DNPEP 839/4885 |
| US-20150183823-A1 | COSMETIC OR PHARMACEUTICAL COMPOSITIONS INCLUDING TRIPEPTIDES CAPABLE OF STIMULATING CYCLIC ADENOSINE MONOPHOSPHATE SYNTHESIS AND THEIR USE IN THE TREATMENT AND/OR CARE OF THE SKIN AND/OR HAIR | MC1R, ADORA3, AMPD3 | ANPEP 87/4885RNPEP 145/4885DNPEP 358/4885 |
| US-20170218015-A1 | PROCESS FOR THE LIQUID PHASE SYNTHESIS OF H-INP-(D)BAL-(D)TRP-PHE-APC-NH2, AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | VIP, IAPP, PROKR1 | ANPEP 64/4885RNPEP 225/4885DNPEP 90/4885 |
| US-20170101438-A1 | COSMETIC OR PHARMACEUTICAL METHODS FOR THE TREATMENT AND/OR CARE OF THE SKIN AND/OR HAIR USING TRIPEPTIDES CAPABLE OF STIMULATING CYCLIC ADENOSINE MONOPHOSPHATE SYNTHESIS | MC1R, ADORA3, AMPD3 | ANPEP 58/4885RNPEP 82/4885DNPEP 255/4885 |
| US-10035820-B2 | Compounds which inhibit neuronal exocytosis | SLC18A2, SLC18A1, ATP6V1B2 | ANPEP 1013/4885RNPEP 1233/4885DNPEP 1574/4885 |
| US-20120021029-A1 | PEPTIDES USED IN THE TREATMENT AND/OR CARE OF THE SKIN AND/OR HAIR AND THEIR USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS | NGLY1, MC1R, NPR3 | ANPEP 86/4885RNPEP 84/4885DNPEP 275/4885 |
| US-20170298097-A1 | Peptide Derivatives and Uses Thereof | VIP, IAPP, NGLY1 | ANPEP 12/4885RNPEP 58/4885DNPEP 13/4885 |
| US-20150140046-A1 | COMPOUNDS WHICH INHIBIT NEURONAL EXOCYTOSIS | SLC18A2, SLC18A1, ATP6V1B2 | ANPEP 1053/4885RNPEP 1370/4885DNPEP 1576/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.